Gallic acid inhibits murine leukemia WEHI-3 cells in vivo and promotes macrophage phagocytosis

In Vivo

Volumn 23, Issue 3, 2009, Pages 409-414

  Ho, Chin Chin ^a   Lin, Shuw Yuan ^b   Yang, Jai Sing ^c   Liu, Kuo Ching ^d   Tang, Yih Jing ^e   Yang, Mei Due ^f   Chiang, Jo Hua ^g   Lu, Chi Cheng ^g   Wu, Chang Lin ^c   Chiu, Tsan Hung ^f   Chung, Jing Gung ^c,d,h  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c Departments of Pharmacology and Biological Science and Technology   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^h ASIA UNIVERSITY   (Taiwan)

Author keywords

BALB c mice; Gallic acid; Macrophage phagocytosis; WEHI 3 leukemia cells

Indexed keywords

CD11 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; GALLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; IN VIVO STUDY; LEUKEMIA; LEUKEMIA CELL; LEUKOCYTE; LIVER WEIGHT; LOW DRUG DOSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEUM CELL; PHAGOCYTOSIS; SPLEEN WEIGHT; SPLENOMEGALY;

EID: 67649717051     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mutoh M, Takahashi M, Fukuda K, Komatsu H, Enya T, Matsushima-Hibiya Y, Mutoh H, Sugimura T and Wakabayashi K: Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship. Jpn J Cancer Res 91(7): 686-691, 2000.
2. Wenzel U, Kuntz S, Brendel MD and Daniel H: Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60(14): 3823-3831, 2000.
3. Ohno Y, Fukuda K, Takemura G, Toyota M, Watanabe M, Yasuda N, Xinbin Q, Maruyama R, Akao S, Gotou K, Fujiwara T and Fujiwara H: Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 10(9): 845-851, 1999.
4. Kawada M, Ohno Y, Ri Y, Dcoma T, Yuugetu H, Asai T, Watanabe M, Yasuda N, Akao S, Takemura G, Minatoguchi S, Gotoh K, Fujiwara H and Fukuda K: Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anticancer Drugs 12(10): 847-852,2001.
5. Su CC, Yang JS, Lin SY, Lu HF, Lin SS, Chang YH, Huang WW, Li YC, Chang SJ and Chung JG: Curcumin inhibits WEHI-3 leukemia cells in BALB/c mice in vivo. In Vivo 22(1): 63-68,2008.
6. Ormerod MG: Flow Cytometry. Oxford University Press, 2000.
7. Lu HF, Liu JY, Hsueh SC, Yang YY, Yang JS, Tan TW, Kok LF, Lu CC, Lan SH, Wu SY, Liao SS, Ip SW and Chung JG: (-)-Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo. In Vivo 21(2): 285-289, 2007.
8. Stachowska E, Baskiewicz-Masiuk M, Dziedziejko V, Adler G, Bober J, Machalinski B and Chlubek D: Conjugated linoleic acids can change phagocytosis of human monocytes/ macrophages by reduction in Cox-2 expression. Lipids 42(8): 707-716,2007.
9. Sakaguchi N, Inoue M and Ogihara Y: Reactive oxygen species and intracellular Ca2+, common signals for apoptosis induced by gallic acid. Biochem Pharmacol 55(12): 1973-1981, 1998.
10. Isuzugawa K, Inoue M and Ogihara Y: Ca2+-Dependent caspase activation by gallic acid derivatives. Biol Pharm Bull 24(7): 844-847,2001.
11. Zhang W, Hashimoto K, Yu GY and Sakagami H: Decline of superoxide dismutase activity during antioxidant-induced apoptosis in HL-60 cells. Anticancer Res 22(1 A): 219-224, 2002.
12. Taghian AG and Suit HD: Animal systems for translational research in radiation oncology. Acta Oncol 38(7): 829-838, 1999.
13. Zips D, Thames HD and Baumann M: New anticancer agents: in vitro and in vivo evaluation. In Vivo 19(1): 1-7, 2005.
14. He Q and Na X: The effects and mechanisms of a novel 2-aminosteroid on murine WEHI-3B leukemia cells in vitro and in vivo. Leuk Res 25(6): 455-461, 2001.
15. Warner NL, Moore MA and Metcalf D: A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content. J Natl Cancer Inst 43(4): 963-982, 1969.